Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
Translated title of the contributionTreating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody
Original languageEnglish
Patent number8535674
Publication statusPublished - 1800

Fingerprint Dive into the research topics of 'Treating Breast Cancer and Inhibiting Cancer-Associated Bone Loss With Anti-IL-20 Antibody'. Together they form a unique fingerprint.

Cite this